NCT05552807 2022-09-23
SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sinocelltech Ltd.
Phase 1 Unknown
Clinical Trials
9 trialsNCT05251766 2022-02-23
Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer
Zhejiang Provincial People's Hospital
Phase 1 Unknown
NCT04811118 2022-01-31
The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT04360317 2020-04-24
Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer
Kyunghee University Medical Center
Phase 1 Unknown
NCT02963168 2019-10-17
A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies
Athenex, Inc.
Phase 1 Unknown
NCT02997332 2019-01-03
MEDINDUCTION
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Unknown
NCT02691871 2016-02-25
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Unknown
NCT02378389 2015-03-04
Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT00003633 2013-12-19
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
National Cancer Institute (NCI)
Phase 1 Unknown